Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294715 is a long non-coding RNA (lncRNA) transcript oriented in the sense direction within an intron of the RNF103-CHMP3 read-through gene. The locus does not encode a protein product and is not recognized as a therapeutic target, receptor, or enzyme. No aliases, functional annotations, disease roles, or drug interactions are currently known for this transcript. Its biological significance remains uncharacterized, and it should not be confused with the protein-coding fusion gene RNF103-CHMP3, which results from a read-through transcription event between the adjacent ring finger protein 103 (RNF103) and charged multivesicular body protein 3 (CHMP3) genes.
Not applicable, as there are no drugs targeting this lncRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel lncRNA transcript located sense intronic to RNF103-CHMP3 (ENSG00000294715).